New Delhi, Jan 14 (IANS) Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low
Even as India is set to soon launch promising new medicine called the DCGI and US FDA-approved Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors while hailing the advance contend that the drug is expensive and .
INCLISIRAN FOR CHOLESTEROL | Docs call it expensive, bat for cheaper options greaterkashmir.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greaterkashmir.com Daily Mail and Mail on Sunday newspapers.
Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available.
Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed .